Moteur de recherche d’entreprises européennes
Financement de l’UE (4 486 750 €) : Outil avancé d’imagerie laser photonique multimodale pour le diagnostic urothélial en endoscopie Hor 01/01/2020 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Outil avancé d’imagerie laser photonique multimodale pour le diagnostic urothélial en endoscopie
There is an absence of lasers with the necessary wavelengths and characteristics to access the possibilities for deeper high-resolution biological tissue imaging in the third bio-window between 1650 nm and 1870 nm. Motivated by recent breakthrough results in multi-photon imaging at twice the depths currently achievable, we will meet the urgent need for new sources to address the outstanding research questions in this spectral region. Results will guide and enable instrument development in this appealing and relatively unexplored biophotonics imaging wavelength range. The AMPLITUDE consortium proposes a new concept of label-free, multi-modal microscopy and endoscopic imaging operating in this new wavelength region with multiple imaging and spectroscopic technologies, including NIR confocal reflectance microscopy, multi-photon microscopy and spontaneous Raman spectroscopy. By progressing ultrafast fibre laser developments at 1700 nm, we will deliver new imaging capabilities in an appropriate form factor and at cost suitable for widespread adoption. This will be further enhanced by providing additional output at 850 nm using second harmonic generation from one integrated laser device. This will enable a pioneering new compact and efficient multi-modal capability combining confocal and non-linear imaging techniques, overcoming performance limitations in medical and biological imaging applications, including improved pathohistological staging of tumours and in-vivo endoscopic assessment of depth of lesion invasiveness. Deeper multi-photon microscopy with autofluorescence imaging of cellular metabolic conditions, whose aspects are tightly related to cellular functioning and to cancer, implemented in tandem with Raman spectroscopy will provide exhaustive characterisation of the examined tissue at morphological, metabolic and molecular levels, allowing in-vivo optical biopsy for bladder cancer diagnosis, grading and staging.
| Ampliconyx Oy | 375 688 € |
| Aston University | 620 658 € |
| Consiglio Nazionale Delle Ricerche | 512 000 € |
| Femtonics Kutato ES Fejleszto kft. | 593 740 € |
| Fundacio Institut de Ciencies Fotoniques | 396 250 € |
| HC Photonics Corporation Ltd. | 0,00 € |
| Modus Research and Innovation Ltd. | 233 750 € |
| Tampereen Korkeakoulusaatio sr | 710 000 € |
| Universita' Degli Studi Di Milano-Bicocca | 330 400 € |
| Universita Degli Studi Di Firenze | 262 500 € |
| Weinert Fiber Optics GmbH | 451 765 € |
https://cordis.europa.eu/project/id/871277
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.